Atypical antipsychotics and metabolic outcomes in Chinese patients: a comparison of olanzapine and risperidone

J Clin Psychopharmacol. 2008 Dec;28(6):707-9. doi: 10.1097/JCP.0b013e31818ce71f.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antipsychotic Agents / administration & dosage*
  • Benzodiazepines / adverse effects*
  • China
  • Cross-Sectional Studies
  • Dose-Response Relationship, Drug
  • Dyslipidemias / chemically induced*
  • Dyslipidemias / metabolism
  • Female
  • Humans
  • Male
  • Metabolic Syndrome / chemically induced*
  • Metabolic Syndrome / metabolism
  • Olanzapine
  • Pilot Projects
  • Risk Factors
  • Risperidone / adverse effects*
  • Schizophrenia / drug therapy*
  • Schizophrenia / metabolism
  • Sex Factors
  • Young Adult

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Risperidone
  • Olanzapine